AbbVie (ABBV) stock gains as company sets 2025 earnings outlook in line with expectations after Q4 revenue beat and despite quarterly loss. Read more here.

Regular MarketWatch readers might already be aware that U.S. stocks are historically expensive right now, based on several popular metrics. Some have argued that this could signal that the market has ...

The rest of the stock market could finally catch up to the Magnificent Seven this year—and it has nothing to do with DeepSeek ...

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current ...

JPMorgan Chase & Co. grew its stake in shares of Lincoln Educational Services Co. (NASDAQ:LINC – Free Report) by 248.7% in ...

Investors aren’t ignoring the upsides of cheaper AI models despite Monday’s DeepSeek-inspired stock-market panic.

Newport Beach-based Elevai last month underwent a company reorganization, including switching parent companies and changing ...

SAN DIEGO, CA / ACCESS Newswire / January 23, 2025 / Dermata Therapeutics, Inc. (NASDAQ:DRMA)(NASDAQ:DRMAW) ("Dermata," or the "Company"), a late-stage biotechnology company focused on the treatment o ...

Decided to add this retail giant to your portfolio? Here's what you need to know before buying Amazon stock. Many, or all, of the products featured on this page are from our advertising partners ...

Shares of AMD have cratered over the past year, making it a rare example of a chip stock that has fallen out of favor with investors. Among investment opportunities in the artificial intelligence ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

The reveal of the Nintendo Switch 2 boosted the company's stock to $15.77 per share, a 52-week high. Several Nintendo stock value jumps were recorded throughout 2024, largely tied to rumors about ...